News - Biotechnology
Biotechnology sector grows in India
16 February 2013
New Delhi, Feb 15 (ANI): The biotechnology sector in India has reached an estimated size of US$ 3.8 billion in value over FY12, and is expected to reach US$ 10.4 billion by 2015. India offers a combination of skilled manpower, low costs, and a large ...
Click on the link to read the full article at indiablooms (This link will open in a new window)Biotechnology sector grows in India Feb 15, 12:53 pm
15 February 2013
New Delhi, Feb 15 (ANI): The biotechnology sector in India has reached an estimated size of US$ 3.8 billion in value over FY12, and is expected to reach US$ 10.4 billion by 2015. India offers a combination of skilled manpower, low costs, and a large ...
Click on the link to read the full article at ANINEWS (This link will open in a new window)Body formed to promote biotechnology in Pakistan
15 February 2013
LAHORE ? To promote the culture of GM crops and agricultural biotechnology in Pakistan, a committee has been formed which will create awareness among the farmers and other stakeholders and would also work to remove the legal hindrances in this ...
Click on the link to read the full article at The Nation (This link will open in a new window)Cytos Biotechnology Announces Full Year 2012 Financial Results
14 February 2013
Funds available for financing the Company's operations amount to CHF 28.70 million as per December 31, 2012, and include cash and cash equivalents, financial assets and trade and other receivables. They were slightly lower than at the end of December ...
Click on the link to read the full article at The Herald | HeraldOnline.com (This link will open in a new window)Cytos Biotechnology Announces Full Year 2012 Financial Results
14 February 2013
Funds available for financing the Company's operations amount to CHF 28.70 million as per December 31, 2012, and include cash and cash equivalents, financial assets and trade and other receivables. They were slightly lower than at the end of December ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)5 Biotechnology Stocks to Buy Now
13 February 2013
This week, five Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an ?A? (?strong buy?) or ?B? overall (?buy?). Dyax (NASDAQ:DYAX) is progressing from last week's rating of B (?buy?) as the ...
Click on the link to read the full article at Investorplace.com (This link will open in a new window)Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High
11 February 2013
NEW YORK, NY -- (Marketwire) -- 02/11/13 -- A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index (IBB), the SPDR S&P Biotech ...
Click on the link to read the full article at SYS-CON Media (press release) (This link will open in a new window)Biotechnology: NABDA DG harps on importance of bio-safety bill
11 February 2013
Management of biotechnology in Nigeria - The Director General National Biotechnology Development Agency (NABDA), Prof. Bamidele Solomon, has harped on the essence of the bio-safety bill to the management of biotechnology in Nigeria. This, he said ...
Click on the link to read the full article at Afrique en Ligue (This link will open in a new window)Battle against cancer is driving rapid growth of biotechnology sector
10 February 2013
The battle to beat cancer and the hunt for ways to live more healthily for longer are driving rapid growth in the biotechnology sector. One of the leading figures is Dr Julie Barnes, co-founder of London-based Abcodia, which she set up two years ago ...
Click on the link to read the full article at This is Money (This link will open in a new window)BioTime acquires Geron's stem cell program
8 February 2013
Nature Biotechnology. Full text access provided to Googlebot Access by Web Services. Search Go Advanced search · nature.com · journal home · current issue · News; full text. Nature Biotechnology | News. Print; Email; Share/bookmark. Cite U Like ...
Click on the link to read the full article at Nature.com (This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
